Harjeet Singh

Title: Harjeet Singh: Innovator in Chimeric Antigen Receptors

Introduction

Harjeet Singh is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptors (CAR). With a total of 2 patents, Singh's work is paving the way for advancements in cancer treatment and immunotherapy.

Latest Patents

Singh's latest patents focus on methods of generating chimeric antigen receptors. These patents provide innovative methods for library screening of CAR by generating a vector encoding the CAR from random attachment of vectors from libraries of vectors encoding antigen-binding domains, hinge regions, and endodomains. In some embodiments, the vectors contain a transposon, enhancing the efficiency of CAR development.

Career Highlights

Harjeet Singh is affiliated with the University of Texas System, where he continues to push the boundaries of research in immunotherapy. His work has garnered attention for its potential to revolutionize cancer treatment through targeted therapies.

Collaborations

Singh collaborates with esteemed colleagues, including Laurence J. N. Cooper and Ana Beatriz Korngold, who contribute to his research endeavors. Their combined expertise fosters an environment of innovation and discovery.

Conclusion

Harjeet Singh's contributions to the field of chimeric antigen receptors exemplify the impact of innovative research in biotechnology. His patents and collaborations highlight the importance of teamwork in advancing medical science.